As of last August, the National Institutes of Health had awarded $374 million to testing companies, compared to the $9 billion pledged to vaccine makers. Critics point to the amount of federal funding allocated during the Trump Administration. Other tests include the Lucira COVID-19 All-In-One-Test Kit, the Ellume COVID-19 Home Test, and the BinaxNOW COVID-19 Ag Card Home Test.Ĭompared to the development of vaccines, testing has evolved at a slower pace.
![quick vue quick vue](https://hardydiagnostics.com/wp-content/uploads/2018/03/qv_influenza_ab_0.png)
Quidel’s test is the fourth authorized by the FDA in recent weeks. But at-home tests that offer rapid results on the spot like a pregnancy test are not yet widely available. “If we can test frequently at home, we can protect communities and make it safe for all of us to go to restaurants and schools,” he said in an interview.įully at-home tests like Quidel’s are a newly emerging part of the diagnostic landscape, one the Biden Administration says will be crucial to getting life back to normal.įor months, consumers have had access to dozens of “home collection tests,” where users swab themselves and mail back samples to an outside lab for processing. Initially, the QuickVue At-Home COVID-19 Test from Quidel Corporation will only be available with a doctor’s prescription, but the company will pursue a second authorization in the coming months to sell the test over-the-counter, according to CEO Douglas Bryant. SAN DIEGO (KGTV) - A San Diego company just got emergency authorization from the Food and Drug Administration to sell a self-test for COVID-19 that returns results in 10 minutes, entirely from home.